Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on the lung stents market provides in-depth analysis of
segments and sub-segments in the global as well as regional lung stents market.
The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional lung stents market over the short term as
well as the long term. The report is a comprehensive presentation of trends,
forecast and dollar values of the global lung stents market. According to the
report, the global lung stents market is projected to grow at a CAGR of over 5%
over the forecast period of 2022-2028.
The global lung stents market was
valued at USD about 100 million in 2022 and is expected to reach USD nearly 150
million in 2028, with a CAGR of over 5% during the forecast period. Increasing
minimally invasive surgeries for respiratory problems will enhance the lung
stents market demand during the forecast period. Patients undergoing minimally
invasive procedures for respiratory conditions experience faster recovery,
fewer complications, shorter hospital stays, and reduced blood loss. As a
result, bronchoscopy, a non-surgical minimally invasive procedure for stent
placement is being widely adopted at a high pace, thereby uplifting the demand
for lung stents. Several advancements in minimally invasive procedures also are
augmenting the number of individuals preferring minimally invasive procedures
for the treatment of breathing problems. The increasing incidences of carcinoma
have led to the increasing adoption of minimally invasive surgeries to bypass
pain.
The demand for lung stents is
increasing because of the increasing incidences of lung cancer and also the
growing elderly population worldwide. Additionally, new innovations and
technological advancements are driving the expansion of this market. 3D printing
technology is utilized to manufacture drug-coated and patient-specific stents.
These stents are coated with medicine to prevent excess tissue growth.
Companies are using innovative technologies to develop advanced stents like
patient-specific. Patients having congenital cystic adenomatoid having
difficulty in breathing prefer stent placement. Therefore, the use of airway
stents is significantly increasing and as a result, the demand for lung stents
is expanding. Moreover, the placement of lung stents is cost-effective as
compared to traditional procedures and has reduced the danger of complications.
The dearth of skilled professionals and therefore the high cost of the
treatment is restraining the growth of the market. Furthermore, Damage to the
vessel from the catheter, an infection caused while inserting the stent, and
irregular heartbeats are a number of factors that will hamper the expansion of
the market.
The outbreak of the COVID-19
epidemic is an unprecedented effect on public health concerns and on the lung
stents market. Healthcare professionals across the world have postponed
minimally invasive surgeries to decline the chance of patients being exposed to
COVID-19 in hospitals, thereby supporting the hospitals in converting operating
theatres into medical care units. However, the high risk of significant
complications because of the spread of the virus decreased the demand for
stents during the covid-19 pandemic period. Further, the development of
advanced vascular stents was also decreased during the covid-19 pandemic which
hampered the market growth.
The global lung stents market is
segmented into the Asia Pacific, North America, Europe, and also the Mideast
& Africa. Among the regions, North America holds a major market share. The
presence of major manufacturers, well-established healthcare infrastructure,
and high awareness amongst surgeons resulted in the increasing adoption of
those stents within the region. Moreover, the Asia Pacific region will grow at
the fastest rate during the forecast period. The expansion of the region is
attributed to the growing geriatric population, rising healthcare expenditure,
and increasing prevalence of diseases. High adoption of therapeutic treatments
like bronchoscopy, chemotherapies, and endoscopic therapy because of a rise in
the prevalence within the geriatric population will further drive the market
growth in the region.
The report on the global lung stents
market covers segments such as type, product, and end-use. On the basis of
type, the sub-markets include self-expandable, and balloon-expandable. On the
basis of product, the sub-markets include tracheal stents, bronchial stents,
and laryngeal stents. On the basis of end-use, the sub-markets include
hospitals, ambulatory surgical centers, and others.
The report provides profiles of
the companies in the market such as Boston Scientific, Taewoong Medical, Merit
Medical Systems, Inc., MICRO-TECH (Nanjing) Co., Ltd., Boston Medical Products,
Inc., Hood Laboratories., Cook Group, ENDO-FLEX GmbH, Meditek Systems Pvt.
Ltd., and Stening.
The report provides deep insights
into demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the lung stents market. Moreover, the study highlights current market
trends and provides forecast from 2022-2028. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players.
Please Choose One of them.